Telomir Pharmaceuticals, Inc.

Ownership Transactions Reported by 14 Insiders

Symbol
TELO on Nasdaq
Location
100 Se 2 Nd St, Suite 2000 #1009, Miami, FL

There are no Buy or Sell transactions made by insiders since 11/5/2023

Telomir Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Bradley Kroenig Director Feb 8, 2024
Christopher Chapman CEO & Chairman, Director Feb 8, 2024
Nathen Fuentes Chief Financial Officer Feb 8, 2024
Bay Shore Trust 10%+ Owner Feb 13, 2024
Talhia Tuck Director Feb 8, 2024
Christos Nicholoudis General Counsel, Director Feb 8, 2024
Craig Eagle Director Feb 8, 2024
Hugh McColl III Director Feb 8, 2024
Michael Jerman Director Aug 27, 2024
Edward Clouston MacPherson Director Aug 27, 2024
Matthew Pratt Whalen Director Aug 27, 2024
Matthew Del Giudice Director Aug 27, 2024
Michelle Yanez Chief Financial Officer Aug 27, 2024
Erez Aminov CEO & Chairman, Director Aug 27, 2024

Recent Insider Transactions by Companies or Individuals for Telomir Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.